Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Intangibles (2024 - 2025)

Historic Intangibles for Century Therapeutics (IPSC) over the last 2 years, with Q3 2025 value amounting to $34.2 million.

  • Century Therapeutics' Intangibles rose 118.34% to $34.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.2 million, marking a year-over-year increase of 118.34%. This contributed to the annual value of $34.2 million for FY2024, which is N/A changed from last year.
  • Per Century Therapeutics' latest filing, its Intangibles stood at $34.2 million for Q3 2025, which was up 118.34% from $34.2 million recorded in Q2 2025.
  • Over the past 5 years, Century Therapeutics' Intangibles peaked at $34.2 million during Q4 2024, and registered a low of $33.3 million during Q2 2024.